Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells
- 1 June 1996
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 18 (6-7) , 393-399
- https://doi.org/10.1016/s0192-0561(96)00044-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comparison of immunomodulative effects of histamine-2 receptor antagonists in gastric cancer patients: Focus on the lymphoblastogenesis and cytotoxicity of peripheral blood mononuclear cellsInternational Journal of Immunopharmacology, 1994
- Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.Gut, 1994
- Protein kinase C inhibits cyclic adenosine monophosphate generation by histamine and truncated glucagon like peptide 1 in the human gastric cancer cell line HGT-1.Gut, 1993
- Chemotherapy of carcinoma of the stomachCancer Treatment Reviews, 1993
- Histamine2-Receptor AntagonistsNew England Journal of Medicine, 1990
- Role of histamine in tumor developmentTrends in Pharmacological Sciences, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- CIMETIDINE REDUCTION OF TUMOUR FORMATION IN MICEThe Lancet, 1981
- CIMETIDINE-INDUCED AUGMENTATION OF HUMAN LYMPHOCYTE BLASTOGENESIS BY MITOGEN, BACTERIAL ANTIGEN, AND ALLOANTIGENTransplantation, 1980
- ANTITUMOUR EFFECT OF CIMETIDINE?The Lancet, 1979